Publications

What is the cost for the book?

The book is free through the generous support of our donors

About the Authors:

Dr. Ghassan K. Abou-Alfa, and Dr. Eileen M. O’Reilly are both associate members of the Gastrointestinal Oncology (GI) Service at Memorial Sloan-Kettering Cancer Center, and associate professors of Medicine at Weill Medical College of Cornell University in New York. They met at MSKCC and have been married and working collaborately ever since. Their research and clinical activities focus on finding novel therapies and improving the effectiveness of current treatments for biliary, primary liver, and pancreatic cancers.

Both Drs. Abou-Alfa and O’Reilly serve on the Scientific Medical Advisory Board (SMAB) of the Cholangiocarcinoma Foundation and are strong advocates for raising awareness and enhancing oncologic education worldwide.

Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers

Second Edition


The free Nutrition & Cholangiocarcinoma book is now available. The resource was produced in partnership with the Oncology Dietician Practice Group (ON DPG). It addresses frequently asked questions about nutrition and gives patients information to help them choose the right foods to eat before, during, and after cancer treatment. 

The free resource empowers patients to make decisions that are best for them. Building and sustaining a healthy body during cancer is essential for a patient’s overall well-being.

The digital version is available in English, Traditional Chinese, (繁體中文), French (Français), Japanese (日本語), and Spanish (Español).

Readers will learn how to improve their health with advice from experts and easy-to-make recipes. You can download a digital copy by completing a brief survey below:

An FGFR (Fibroblast Growth Factor Receptor) alteration such as a fusion or rearrangement can lead to abnormal cell growth and is often linked to certain cancers. Specifically, an FGFR2 mutation affects cell division and growth, making it a target for treatments.

If you have an FGFR alteration such as a fusion or rearrangement, you are eligible for a free care kit.

Complete this short order form, and we will mail kits to all eligible households within ten business days.
Eligible households include:

  • The patient has the FGFR2 mutation.
  • The patient lives in the United States.